Research programme: therapeutics - Schrodinger/Structure Therapeutics
Latest Information Update: 16 Jan 2024
At a glance
- Originator Schrodinger; Structure Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 20 Dec 2023 Early research in Unspecified in USA (unspecified route), before December 2023 (Schrodinger pipeline, December 2023)